Digital Acupressure App Significantly Reduces Cancer Fatigue
- A new study offers hope for women experiencing persistent fatigue following ovarian cancer treatment.
- The randomized clinical trial, published in February 5, 2026, in JAMA Network Open, involved 160 ovarian cancer survivors struggling with fatigue.
- The primary outcome measured the change in BFI scores from the beginning of the study to week six.
A new study offers hope for women experiencing persistent fatigue following ovarian cancer treatment. Researchers at the University of Michigan have found that self-acupressure, learned through a smartphone app, significantly reduced cancer-related fatigue compared to both sham acupressure and usual care.
The randomized clinical trial, published in , in JAMA Network Open, involved 160 ovarian cancer survivors struggling with fatigue. Participants were randomly assigned to six weeks of either true self-acupressure (TSA), sham self-acupressure (SSA), or usual care (UC). The study, conducted between and , recruited participants through tumor registries and social media, focusing on those reporting a high level of fatigue as measured by the Brief Fatigue Inventory (BFI).
The primary outcome measured the change in BFI scores from the beginning of the study to week six. Secondary outcomes included sleep disturbance assessed by the Pittsburgh Sleep Quality Index, quality of life measured by the Functional Assessment of Cancer Therapy-Ovarian questionnaire, and BFI scores at weeks 12 and 24. The results demonstrated that both TSA and SSA groups experienced significantly greater reductions in fatigue compared to the UC group. By the end of the six-week intervention, 58.5% of the TSA group and 51.1% of the SSA group reported normal fatigue levels, compared to only 17.6% in the UC group.
Acupressure, a technique rooted in Traditional Chinese Medicine (TCM), involves applying physical pressure to specific points on the body. The study leveraged a modern approach by delivering instructions through a mobile app, guiding participants to stimulate therapeutic points. The researchers noted that stimulating points like Sanyinjiao (SP6) activates nerve fibers, sending signals to the brain and spinal cord. This activation can lead to the release of endorphins and neurotransmitters like serotonin, potentially reducing pain perception and improving mood. Importantly, the intervention appeared to facilitate a shift from the sympathetic to the parasympathetic nervous system, a change often difficult to achieve for cancer patients.
The use of a mobile app to deliver this therapy represents a significant innovation. It overcomes barriers associated with the cost and logistical challenges of frequent in-person appointments and standardizes the treatment process, minimizing potential errors. Notably, the study reported no adverse events, suggesting the method is safe. This app-based solution could potentially alleviate the burden on healthcare systems by offering a cost-effective and accessible intervention.
Fatigue is a debilitating symptom experienced by many cancer patients, significantly impacting their quality of life and sleep. Current clinical recommendations often include self-acupressure, but access can be limited. This study suggests a mobile app can overcome these obstacles, providing a practical and scalable solution.
The implications of this research extend beyond ovarian cancer. Fatigue is a common problem across many cancer types, and effective treatment options remain limited. Dr. Suzanna M. Zick and her team at the University of Michigan have previously conducted research on the application of acupressure for fatigue in breast cancer, further supporting the potential for broader applicability. Future developments could involve combining acupressure apps with cognitive behavioral therapy (CBT) to create comprehensive digital platforms for symptom management. CBT-I, or Cognitive Behavioral Therapy for Insomnia, is another approach to improving sleep and overall well-being, though this study did not specifically focus on its integration with acupressure.
While the sham acupressure group also showed significant improvement, the researchers acknowledge the importance of understanding the placebo effect and the potential benefits of simply engaging in a self-care practice. Further research is needed to determine the optimal duration of treatment and to identify which patients are most likely to benefit from this intervention. However, the findings offer a promising new avenue for managing cancer-related fatigue and improving the lives of survivors.